Attention-deficit hyperactivity disorder

Attention-deficit hyperactivity disorder

A community portal about Attention-deficit hyperactivity disorder with blogs, videos, and photos. According to Wikipedia.org: Attention-Deficit/Hyperactivity Disorder is thought to be a neurological disorder, always present from... [more]

A community portal about Attention-deficit hyperactivity disorder with blogs, videos, and photos. According to Wikipedia.org: Attention-Deficit/Hyperactivity Disorder is thought to be a neurological disorder, always present from childhood, which manifests itself with symptoms such as hyperactivity, forgetfulness, poor impulse control, and distractibility. In neurological pathology, ADHD is currently considered to be a chronic syndrome for which no medical cure is available. ADHD is believed to affect between 3-5% of the United States population, including both children and adults.

Sorted by: Top Picks
Written by wirelesscyclecompute on
ADHD refers to attention-deficit-hyperactivity-disorder. Most children who suffer from this disorder suffer from attention problems as well as hyperactivity. Parents of such children are well aware that inattention and hyperactivity continue throughout the day. Keeping such children busy after school hours can be as difficult as keeping them safe during the school day. The first step while choosing the right after school activity for your child is to understand how ADHD affects him. Is your child interested in sports? Is he put off by the fierce competitiveness, or does he find it hard to get along with teammates? Does your child vocalize his feelings, ... Read Full Story
Written by billys_office on
Everyone is at risk of catching the H1N1 flu virus. However, the following groups are more at risk of developing complications if they do get sick: Children under 5 years old Women who are pregnant People with chronic conditions such as: Heart disease Kidney disease Diabetes Asthma and chronic lung disease liver disease Blood disorders Severe obesity Immunosuppressed (people taking cancer drugs or people with HIV/AIDS) Neurological disorders Related Websites FDA Is Going To Approve Genetically Engineered Animals For Our Food Chain. Genetically Engineered grains have been in existence for several years, amidst many concerns from various organizations and individuals. Now, the FDA is ... Read Full Story
Written by yokoshi on
New findings presented today show that CONCERTA is the only stimulant medication with data that demonstrate a significant treatment effect on attention at one hour and through 12.5 hours in children with Attention Deficit Hyperactivity Disorder (ADHD). ADHD is a common and treatable child behavioral problem characterized by inattention, hyperactivity and impulsivity(1) that is estimated to affect about 5 million children(2) in the United States. Read Full Story
Written by Ernie6274 on
This show will offer information and support about ADHD for those who are dealing with it on a daily basis. ADHD | Attention | Deficit | Hyperactivity | Disorder Read Full Story
There's more worrisome news about the potential risks to humans from exposure to the chemical bisphenol A (BPA), which is used to make such products as plastic water bottles, plastic baby bottles, and the linings in food cans. A study published today in the online journal http://www.ehponline.org/ Environmental Health Perspectives revealed exposure to BPA in early pregnancy was linked to aggression and hyperactivity in the women's two-year-old girls. But the study -- "Prenatal Bisphenol A Exposure and Childhood Behavior Environmental Health Perspectives" -- found no significant effects from BPA exposure in the women's sons. "This is first human study to examine the association of ... Read Full Story
Sorted by: Top Rated
Click to play video
Sorted by: Top Rated
No pictures yet.
Sponsors
Low folate levels during pregnancy are associated with higher odds for attention-deficit/hyperactivity disorder in offspring aged 7 to 9, new research has found. The findings seem to support the long-held belief that folate (folic acid) levels in expectant mothers influence their children's nervous system development. The researchers also found that children of mothers with low folate levels had notably smaller head circumference at birth...  
From blogger.com ()
More perspectives...
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, has announced that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV™ (guanfacine) Extended Release Tablets, Vyvanse® (lisdexamfetamine dimesylat  
From medicalnewstoday.com ()
More perspectives...
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV- (guanfacine) Extended Release Tablets, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, and Daytrana- (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.  
From news-medical.net ()
More perspectives...
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.  
From news-medical.net ()
More perspectives...
HONOLULU, Oct. 29 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of...  
From rss.prnewswire.com ()
More perspectives...
More From Zimbio
Copyright © 2009 - Zimbio, Inc. Some rights reserved.